Comparison of immune modulatory derivatives in patients with AL
Regimen, source . | No. . | No prior Rx, % . | 2 or more organs, % . | Cardiac, % . | Heme response, % . | Organ response, % . | Median f/u, mo . | Grade 3-4 AEs, % . |
---|---|---|---|---|---|---|---|---|
Dex | ||||||||
Palladini et al7 | 23 | 43 | 48 | 39 | 13 | 30 | 39 | NR |
Gertz et al8 | 25 | 100 | NR | 68 | 40 | 12 | 18 | NR |
Gertz et al9 | 19 | 0 | NR | 63 | 53 | 16 | 27 | NR |
Dex-IFN | ||||||||
Dhodapkar et al10 | 87 | 84 | 71 | 50 | 27 | 17 | 41 | 46/53‡ |
Thal/Dex | ||||||||
Palladini et al27 | 31 | 42 | 61 | 38 | 48 | 26 | 32 | 65 |
Thal | ||||||||
Seldin et al28 * | 16 | 6 | 31 | 25 | 25 | 0 | NR | 50 |
Dispenzieri et al29 * | 12 | 58 | 67 | 42 | 0 | 11 | 2.3§ | 58 |
Dispenzieri et al30 † | 18 | 28 | 50 | 67 | 0 | 11 | 5.6§ | 75 |
Len with or without Dex | ||||||||
Current study | 22 | 43 | 57 | 65 | 43 | 26 | 17 | 83 |
Regimen, source . | No. . | No prior Rx, % . | 2 or more organs, % . | Cardiac, % . | Heme response, % . | Organ response, % . | Median f/u, mo . | Grade 3-4 AEs, % . |
---|---|---|---|---|---|---|---|---|
Dex | ||||||||
Palladini et al7 | 23 | 43 | 48 | 39 | 13 | 30 | 39 | NR |
Gertz et al8 | 25 | 100 | NR | 68 | 40 | 12 | 18 | NR |
Gertz et al9 | 19 | 0 | NR | 63 | 53 | 16 | 27 | NR |
Dex-IFN | ||||||||
Dhodapkar et al10 | 87 | 84 | 71 | 50 | 27 | 17 | 41 | 46/53‡ |
Thal/Dex | ||||||||
Palladini et al27 | 31 | 42 | 61 | 38 | 48 | 26 | 32 | 65 |
Thal | ||||||||
Seldin et al28 * | 16 | 6 | 31 | 25 | 25 | 0 | NR | 50 |
Dispenzieri et al29 * | 12 | 58 | 67 | 42 | 0 | 11 | 2.3§ | 58 |
Dispenzieri et al30 † | 18 | 28 | 50 | 67 | 0 | 11 | 5.6§ | 75 |
Len with or without Dex | ||||||||
Current study | 22 | 43 | 57 | 65 | 43 | 26 | 17 | 83 |